Jumbotron-image_large

Webcasts

2020 Webcasts

Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma 

Released on 5/22/20
Expires on 5/22/21

New Paradigms in the Treatment of Relapsed Multiple Myeloma

Released on 5/4/20
Expires on 5/4/21

New Paradigms in the Treatment Options for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML): European Perspective

Released on 4/28/20
Expires on 4/28/21

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma

Released on 12/30/19
Expires on 2/30/20

Changing Landscape of Treatment of HR+ and HER2- Metastatic Breast Cancer with PI3K and CDK 4/6 Inhibitors

Released on 12/26/19
Expires on 2/26/20

2019 Webcasts

Changing Landscape of Treatment Options for ALL with CD19, CD22 Monoclonal Antibodies and AML with IDH1/2, FLT3, CD33 and Hedgehog Pathway Targeted Agents

Released on 9/17/19
Expires on 9/17/20

Changing Landscape of Therapies for Urothelial Carcinoma and Non-Muscle-Invasive Bladder Cancer with PD-1/PD-L1 Inhibitors, ADC and Recombinant Adenovirus Mediated Interferon-α2b

Released on 6/24/19
Expires on 6/24/20

Evolving Landscape of Treatment for Hepatocellular Carcinoma with Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy

Released on 6/24/19
Expires on 6/24/20

Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers

Released on 6/12/19
Expires on 6/12/20

Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents

Released on 6/10/19
Expires on 6/10/20

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia

Released on 5/13/19
Expires on 5/13/20

Optimizing Outcomes in Patients with Malignant Melanoma Treated with Targeted Agents, Checkpoint Inhibitors and Oncolytic Viral Therapiesr

Released on 12/30/18
Expires on 12/30/19

Emerging Novel PI3K Inhibitors, Anti-CD20 mAb and Combination Therapy Options for Follicular Lymphoma

Released on 12/30/18
Expires on 12/30/19

Changing Landscape of Treatment Strategies of TKI Interruptions, Discontinuations and Switching in Patients with Chronic Myeloid Leukemia

Released on 12/30/18
Expires on 12/30/19

Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy

Released on 12/30/18
Expires on 12/30/19

View All Enduring Webcast Programs